ENTITY
Grifols SA

Grifols SA (GRF SM)

82
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Grifols SA
•11 Oct 2019 18:09

Grifols' (GRF) Bleeding Prefs

Grifols Class B shares listed on Nasdaq (GFRS US) are trading at a 33.4% discount to Grifols class A shares (GFR SM), listed in Spain. I regard...

Share
•20 Sep 2019 03:06

China Biologic's Privatisation Redux

On Wednesday after market close, China Biologic Products (CBPO US) announced a surprising privatisation bid from a consortium for $120 per ADS. The...

Logo
876 Views
Share
bearish•MSCI World Index
•12 Aug 2019 09:31

Global Equity Strategy: Another Test of Support

Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no...

Logo
477 Views
Share
x